Oral medicine preparation for treating chronic cholecystitis

Abstract

The invention discloses an oral medicine preparation for treating chronic cholecystitis. The oral medicine preparation is prepared from the following bulk drugs in parts by weight: 20-30 parts of angelica dahurica, 20-30 parts of cassia twigs, 5-15 parts of buthus martensi karsch scorpion, 5-15 parts of semen oroxyli, 10-20 parts of common selfheal fruit-spikes, 10-20 parts of climbing groundsel herbs, 5-15 parts of longtube ground ivy herbs, 20-30 parts of forsythia suspensa, 20-30 parts of coastal glehnia roots, 10-20 parts of lancea tibetica, 5-15 parts of roots of Indian kalimeris herbs, 10-15 parts of immature orange fruits, and 2-5 parts of musk. During treatment, the oral medicine preparation is taken orally twice a day, and 2-4 grams of the oral medicine preparation is taken each time. In one course of treatment, a patient takes the oral medicine preparation for 15 days continuously. For a patient with a slight state of the chronic cholecystitis, after the patient takes the oral medicine preparation for 2-3 courses of treatment, the chronic cholecystitis is healed; and for a patient with a serious state of the chronic cholecystitis, after the patient takes the oral medicine preparation for 3-5 courses of treatment, the chronic cholecystitis is healed. The oral medicine preparation for treating the chronic cholecystitis mainly treats the chronic cholecystitis, and through the application of the oral medicine preparation for many years, the effective rate reaches more than 95%. The oral medicine preparation has the advantages of stable therapeutic effect, significant effect, no toxic or side effects, low cost and the like.

Description

technical field [0001] The invention relates to an oral pharmaceutical preparation for treating chronic cholecystitis. Background technique [0002] Chronic diseases mainly refer to cardiovascular and cerebrovascular diseases (hypertension, coronary heart disease, stroke, etc.), diabetes, malignant tumors, chronic obstructive pulmonary disease (chronic bronchitis, emphysema, etc.), mental disorders and mental illnesses, etc. A group of diseases characterized by long course of disease, complex etiology, serious health damage and social harm. At present, the prevention and treatment of chronic diseases has become one of the key research topics of the Ministry of Health, scientific research institutions, and hospitals. In the next few years, a large amount of funds and manpower will be invested in research on the prevention and control of chronic diseases. [0003] Cholecystitis is an inflammation caused by the invasion of biliary system by bacteria, stones, and chemical facto...

AI Technical Summary

Problems solved by technology

At present, anti-inflammatory and choleretic drugs are mostly used in the treatment of this disease, such as anti-inflammatory and choleretic tablets and anti-cholesterol tablets. Some patients whose symptoms are not relieved sometimes take digestive drugs such as Jianwei Xiaoshi tablets. The effects are not satisfactory, and there are shortcomings such as unstable curative effect, long course of treatment, many side effects, high price, slow effect, etc.